Real questions from health communities, answered with cited research from PubMed and Vellito's article corpus. Plain language, no medical advice. How this works.
Yes, Cimlanod significantly increases the risk of low blood pressure (hypotension) in patients with heart failure with reduced ejection fraction, according to a meta-analysis.
Yes, adding qiliqiangxin to your current treatment may reduce cardiovascular death and heart failure hospitalization in HFrEF, based on a large trial and meta-analysis.
Capecitabine is not a standard treatment for triple-negative breast cancer (TNBC); trastuzumab emtansine targets HER2-positive cancer, not TNBC. Neither is considered effective…
Yes, adding immune checkpoint inhibitors (like pembrolizumab) to chemotherapy improves event-free survival and pathologic complete response in early-stage triple-negative breast…
Yes, blood test scores like COP-MPV, mGPS, NLR, and PLR are linked to survival in OSCC, but they are not precise enough to predict individual survival time.
New immunotherapy options for triple-negative breast cancer include immune checkpoint inhibitors like pembrolizumab combined with chemotherapy, which improve survival in…
Yes, research shows that the oral microbiome, including bacteria like Veillonella, shifts as OSCC progresses, with different patterns in early vs. advanced stages.
Yes, new treatments targeting cell death pathways like ferroptosis, cuproptosis, and autophagy are being studied for oral squamous cell carcinoma, with some showing promise in…
Yes, machine learning models show good accuracy for diagnosing MASH and fibrosis, with pooled AUROCs around 0.83-0.84, but they are not yet ready to replace liver biopsy in…
Yes, diaphragm ultrasound combined with the Diaphragmatic Rapid Shallow Breathing Index (D-RSBI) can predict weaning success in neurocritical patients on mechanical ventilation…
Yes, lowering triglycerides may help treat MASH by reducing liver fat and improving inflammation, but more research is needed to confirm long-term benefits.
Yes, selective decontamination of the digestive tract (SDD) likely reduces hospital mortality in mechanically ventilated ICU patients, though results vary across studies.
For non-cirrhotic MASH, drugs targeting metabolism and insulin sensitivity (e.g., tirzepatide, semaglutide) work best, but lifestyle changes and weight loss are foundational.
No, a low-use wrist-strap strategy did not improve days free of delirium or coma compared to a high-use strategy in mechanically ventilated adults.
Based on a survey, about 1 in 4 US adults aged 45 and older with hearing loss use hearing aids, with usage increasing with age.
Yes, selective decontamination of the digestive tract (SDD) likely reduces hospital mortality in mechanically ventilated ICU adults, based on a large meta-analysis showing a 9%…
Brolucizumab and aflibercept both improve vision in diabetic macular edema, but brolucizumab may allow longer intervals between injections while carrying a higher risk of…
Yes, hearing aid use is associated with improved cognitive function and a reduced risk of cognitive impairment in older adults with hearing loss.
Yes, taking aflibercept every 8 weeks maintains vision gains in diabetic macular edema, as shown in a 96-week trial where the 2 mg every 8 weeks regimen kept visual improvements…
Yes, a specific saliva test measuring IgA antibodies to EBNA1 protein can accurately predict NPC risk, with sensitivity up to 90% and specificity over 91%.
Yes, saliva samples can help predict nasopharyngeal carcinoma (NPC) risk by detecting EBV markers and microbial changes, but they are not yet standard for other cancers.
Yes, aflibercept biosimilars are as safe and effective as the original drug for diabetic macular edema, based on a systematic review and meta-analysis.
Yes, helical tomotherapy (a form of IMRT) significantly reduces dry mouth (xerostomia) in nasopharyngeal carcinoma patients by sparing salivary glands, with low rates of severe…
Yes, early studies show suprachoroidal injections of triamcinolone can improve vision and reduce swelling in diabetic macular edema, but more research is needed.
We pull real patient questions from public Reddit health communities (r/AskDocs, r/diabetes, r/menopause, etc.). Each question is rewritten into a generic medical question (no personal details), then answered by an AI using only cited sources from Vellito's article database and PubMed. A second AI independently scores each answer for accuracy and citation fidelity before publication. Answers below the safety threshold or touching emergency, dosing, or pediatric topics are queued for human review and never auto-published.
This is not medical advice. Always speak with your own doctor before making decisions about your health.